| PERIOD ENDING | 28-Feb-09 | 30-Nov-08 | 31-Aug-08 | 31-May-08 | | Total Revenue | 8,137,000 | 9,538,000 | 9,970,000 | 9,866,000 | | Cost of Revenue | 7,226,000 | 5,865,000 | 7,545,000 | 9,133,000 | | | Gross Profit | 911,000 | 3,673,000 | 2,425,000 | 733,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 233,000 | 2,398,000 | 1,303,000 | (485,000) | | Non Recurring |
-
|
-
|
-
| 882,000 | | Others | 496,000 | 491,000 | 492,000 | 499,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 182,000 | 784,000 | 630,000 | (163,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (4,000) |
-
| (3,000) | 44,000 | | Earnings Before Interest And Taxes | 178,000 | 784,000 | 627,000 | (119,000) | | Interest Expense | 19,000 | 10,000 | 9,000 | 48,000 | | Income Before Tax | 159,000 | 774,000 | 618,000 | (167,000) | | Income Tax Expense | 62,000 | 281,000 | 234,000 | 74,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 97,000 | 493,000 | 384,000 | (241,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 97,000 | 493,000 | 384,000 | (241,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $97,000 | $493,000 | $384,000 | ($241,000) |
|
0.45% Nasdaq 
0.20%
Income Statement
